Cargando…
Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells
Aberrant activation of NF-κB is linked with the progression of human malignancies including hepatocellular carcinoma (HCC), and blockade of NF-κB signaling could be a potential target in the treatment of several cancers. Therefore, designing of novel small molecule inhibitors that target NF-κB activ...
Autores principales: | Mohan, Chakrabhavi Dhananjaya, Anilkumar, Nirvanappa C., Rangappa, Shobith, Shanmugam, Muthu K., Mishra, Srishti, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Bhattacharjee, Atanu, Sethi, Gautam, Kumar, Alan Prem, Basappa, Rangappa, Kanchugarakoppal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867297/ https://www.ncbi.nlm.nih.gov/pubmed/29616186 http://dx.doi.org/10.3389/fonc.2018.00042 |
Ejemplares similares
-
Novel 1,3,4-oxadiazole Targets STAT3 Signaling to Induce Antitumor Effect in Lung Cancer
por: Malojirao, Vikas H., et al.
Publicado: (2020) -
Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
por: Nirvanappa, Anilkumar C., et al.
Publicado: (2016) -
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
por: Nirvanappa, Anilkumar C., et al.
Publicado: (2017) -
N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2018) -
Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells
por: Somu, Chaithanya, et al.
Publicado: (2020)